Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Indonesia pharmaceutical market update, 2013

Ames Gross provides an overview of the healthcare environment in Indonesia. Indonesia is home to 250 million people and one of the fastest growing pharmaceutical markets in Asia. The market is currently...

Articles

Market Access for nebulisers in asthma – UK payer insights

As our market access themed month commences, Dr Joanna Entwistle and Julia Glover explore market access barriers to nebulisers for asthma in the UK. Asthma is an inflammatory disease of the airways characterised by chronic inflammation associated with airway hyper-responsiveness...

Articles

Physician online communities – sponsor or build? (part 2)

Kay Wesley concludes her thoughts on whether pharma should sponsor or build physician online communities by exploring the pros and cons of both. In part one of this article, I considered the growth of online physician communities and the different types of community available –third party...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital